| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |